Manon E. Wildenberg

15.5k citations

106 papers · 5.3k · 2 hit papers · h-index 32

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Genetics top 1%
- Inflammatory Bowel Disease
- Mesenchymal stem cell research

Papers in

Surgery 25
- Anorectal Disease Treatments and Outcomes 7
- Diverticular Disease and Complications 7
Genetics 24
- Inflammatory Bowel Disease 20
- Digestive system and related health 4

Co-authors: Gijs R. van den Brink (39 shared papers)Daniël W. Hommes (13 shared papers)Geert D’Haens (36 shared papers)Anne Christine W. Vos (12 shared papers)Marjolijn Duijvestein (14 shared papers)Auke P. Verhaar (10 shared papers)Alon D. Levin (6 shared papers)Andrea van Elsas (1 shared paper)
Journals: Journal of Crohn s and Colitis (29 papers)Gastroenterology (9 papers)Inflammatory Bowel Diseases (5 papers)Gut (4 papers)Cellular and Molecular Gastroenterology and Hepatology (4 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Manon E. Wildenberg

101 papers receiving 5.2k citations

Manon E. Wildenberg's Hit Papers

align trajectories log scale

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study 2010 · 520 citations

Peers

Countries citing papers authored by Manon E. Wildenberg

Since Specialization

Citations

This map shows the geographic impact of Manon E. Wildenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manon E. Wildenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manon E. Wildenberg more than expected).

Fields of papers citing papers by Manon E. Wildenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manon E. Wildenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manon E. Wildenberg. The network helps show where Manon E. Wildenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Manon E. Wildenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manon E. Wildenberg Line = papers co-authored together Manon E. Wildenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses The Journal of Experimental Medicine ·Roger P.M. Sutmuller, Leonie M. van Duivenvoorde, Andrea van Elsas, Ton N. Schumacher, Manon E. Wildenberg, James P. Allison, René E. M. Toes, Rienk Offringa, Cornelis J.M. Melief Hit paper breakdown →	2001	876
2	Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study Gut ·Marjolijn Duijvestein, Anne Christine W. Vos, Helene Roelofs, Manon E. Wildenberg, Barbara B. Wendrich, Henricus W Verspaget, Engelina M C Kooy-Winkelaar, Frits Koning, Jaap Jan Zwaginga, Herma H. Fidder, Auke P. Verhaar, Willem E. Fibbe, Gijs R. van den Brink, Daniël W. Hommes Hit paper breakdown →	2010	520
3	Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis Gastroenterology ·Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg, Desirée van der Kleij, Theo Rispens, Jeroen M. Jansen, Ron A. A. Mathôt, Cyriel Y. Ponsioen, Mark Löwenberg, Geert D’Haens	2015	313
4	Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis Stem Cells ·Marjolijn Duijvestein, Manon E. Wildenberg, Mick M. Welling, Simone D. Hennink, Ilse Molendijk, Vanessa L. van Zuylen, Tjalling Bosse, Anne Christine W. Vos, Eveline S. M. de Jonge‐Muller, Helene Roelofs, Louise van der Weerd, Hein W. Verspaget, Willem E. Fibbe, Anje A. te Velde, Gijs R. van den Brink, Daniël W. Hommes	2011	288
5	Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Alon D. Levin, Manon E. Wildenberg, Gijs R. van den Brink	2016	265
6	Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression Annals of the Rheumatic Diseases ·Zana Brkić, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, Paul Van Daele, Virgil A. S. H. Dalm, Manon E. Wildenberg, Wouter Beumer, Hemmo A. Drexhage, Marjan A. Versnel	2012	246
7	Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner Gastroenterology ·Anne Christine W. Vos, Manon E. Wildenberg, Marjolijn Duijvestein, Auke P. Verhaar, Gijs R. van den Brink, Daniël W. Hommes	2010	175
8	Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling Gut ·Pim J. Koelink, Felicia M. Bloemendaal, Bofeng Li, Liset Westera, Esther Vogels, Manon van Roest, Anouk K. Gloudemans, Angélique B. van ’t Wout, Hannelie Korf, Séverine Vermeire, Anje A. te Velde, Cyriel Y. Ponsioen, Geert D’Haens, J. Sjef Verbeek, Terrence L. Geiger, Manon E. Wildenberg, Gijs R. van den Brink	2019	171
9	Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro Inflammatory Bowel Diseases ·Anne Christine W. Vos, Manon E. Wildenberg, Ingrid Arijs, Marjolijn Duijvestein, Auke P. Verhaar, Gert De Hertogh, Séverine Vermeire, Paul Rutgeerts, Gijs R. van den Brink, Daniël W. Hommes	2011	147
10	Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells European Journal of Immunology ·Manon E. Wildenberg, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, Hemmo A. Drexhage, Marjan A. Versnel	2008	134
11	Blimp1 regulates the transition of neonatal to adult intestinal epithelium Nature Communications ·Vanesa Muncan, Jarom Heijmans, Stephen D. Krasinski, Nikè V.J.A. Büller, Manon E. Wildenberg, Sander Meisner, Marijana Radonjić, Kelly A. Stapleton, W.H. Lamers, Izäk Biemond, Marius A. van den Bergh Weerman, Dónal O’Carroll, James C.H. Hardwick, Daniël W. Hommes, Gijs R. van den Brink	2011	134
12	Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway Gut ·Liudmila L. Kodach, Rutger J. Jacobs, Philip W. Voorneveld, Manon E. Wildenberg, (unknown), Tom van Wezel, Hans Morreau, (unknown), Maikel P. Peppelenbosch, Gijs R. van den Brink, James C.H. Hardwick	2011	121
13	Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Pim J. Koelink, Manon E. Wildenberg, Larry Stitt, Brian G. Feagan, Martin H. Koldijk, Angélique B. van ’t Wout, Raja Atreya, Michael Vieth, Johannan F. Brandse, Suzanne Duijst, Anje A. te Velde, Geert D’Haens, Barrett G. Levesque, Gijs R. van den Brink	2018	112
14	Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice Hepatology ·Davor Slijepcevic, Reinout L.P. Roscam Abbing, Takeshi Katafuchi, Antje Blank, Joanne M. Donkers, Stéphanie van Hoppe, Dirk R. de Waart, Dagmar Tolenaars, Jonathan H. M. van der Meer, Manon E. Wildenberg, Ulrich Beuers, Ronald P.J. Oude Elferink, Alfred H. Schinkel, Stan F.J. van de Graaf	2017	111
15	The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Leonie C.S. De Vries, Manon E. Wildenberg, Wouter J. de Jonge, Geert D’Haens	2017	91
16	Colonic CD90+ Crypt Fibroblasts Secrete Semaphorins to Support Epithelial Growth Cell Reports ·Olga N. Karpus, B. Florien Westendorp, Jacqueline L.M. Vermeulen, Sander Meisner, Jan Köster, Vanesa Muncan, Manon E. Wildenberg, Gijs R. van den Brink	2019	77
17	Autophagy Attenuates the Adaptive Immune Response by Destabilizing the Immunologic Synapse Gastroenterology ·Manon E. Wildenberg, Anne Christine W. Vos, Simone C. Wolfkamp, Marjolijn Duijvestein, Auke P. Verhaar, Anje A. te Velde, Gijs R. van den Brink, Daniël W. Hommes	2012	71
18	Development of Fibrosis in Acute and Longstanding Ulcerative Colitis Journal of Crohn s and Colitis ·Jessica R. de Bruyn, Sybren L. Meijer, Manon E. Wildenberg, Willem A. Bemelman, Gijs R. van den Brink, Geert D’Haens	2015	69
19	Antibody‐mediated activation of the classical pathway of complement may compensate for mannose‐binding lectin deficiency European Journal of Immunology ·Anja Roos, Peter Garred, Manon E. Wildenberg, Nicholas J. Lynch, Jeric R. Munoz, Tahlita C.M. Zuiverloon, Lee H. Bouwman, Nicole Schlagwein, Francien C. Fallaux van den Houten, Maria C. Faber‐Krol, Hans O. Madsen, Wilhelm Schwaeble, Misao Matsushita, Teizo Fujita, Mohamed R. Daha	2004	68
20	A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function Inflammatory Bowel Diseases ·Leonie C.S. De Vries, José Duarte, Manon de Krijger, Olaf Welting, Patricia H. P. van Hamersveld, F W M Van Leeuwen-Hilbers, Perry D. Moerland, Aldo Jongejan, Geert D’Haens, Wouter J. de Jonge, Manon E. Wildenberg	2019	68

About Manon E. Wildenberg

Manon E. Wildenberg is a scholar working on Surgery, Genetics, Immunology, Epidemiology and Molecular Biology, having authored 106 papers that have together received 5.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (20 papers), Anorectal Disease Treatments and Outcomes (7 papers), Diverticular Disease and Complications (7 papers), Autophagy in Disease and Therapy (6 papers), Salivary Gland Disorders and Functions (5 papers), Microscopic Colitis (5 papers), Digestive system and related health (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (1.8k citations), Genetics (678 citations), Genetics (1.3k citations), Oncology (969 citations) and Epidemiology (694 citations). Manon E. Wildenberg has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Gijs R. van den Brink, Daniël W. Hommes, Geert D’Haens, Anne Christine W. Vos, Marjolijn Duijvestein, Auke P. Verhaar, Alon D. Levin, Andrea van Elsas, Leonie M. van Duivenvoorde and Rienk Offringa. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Inflammatory Bowel Diseases, Gut and Cellular and Molecular Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Manon E. Wildenberg

Impact in

Papers in i

In The Last Decade

Manon E. Wildenberg

Manon E. Wildenberg's Hit Papers

Peers

Countries citing papers authored by Manon E. Wildenberg

Fields of papers citing papers by Manon E. Wildenberg

All Works

About Manon E. Wildenberg

Explore authors with similar magnitude of impact

Papers in